Telomerase as a potential molecular target to study G-quartet phosphorothioates

被引:27
作者
Sharma, HW
Hsiao, RS
Narayanan, R
机构
[1] Oncology Division, Roche Research Center, Hoffmann-La Roche, Inc., Nutley
[2] Oncology Division, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, NJ 07110
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1996年 / 6卷 / 01期
关键词
D O I
10.1089/oli.1.1996.6.3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of gene expression by phosphorothioate oligomers is complex and involves specific and nonspecific mechanisms, Oligomers that contain a G-quartet elicit distinct effects in vitro and in vivo that are dependent on the context of the G-quartet's occurrence within a sequence. The enzyme telomerase, a ribonucleoprotein, has a stretch of C residues in the RNA template, which are used to add terminal dG-rich telomeric repeats to the ends of chromosomes, Some but not all phosphorothioates containing a G-quartet, depending on the context of occurrence, inhibited telomerase activity in vitro, Non-G-quartet phosphorothioates did not inhibit this activity, Activities of control enzymes, such as reverse transcriptase or fag polymerase, were not affected by the G-quartet oligomers. Neither phosphodiester nor chimeric oligomers of a G-quartet-containing oligomer were as potent in inhibition of telomerase activity as phosphorothioate oligomers, These results may provide a molecular target to study the effects of G-quartet-containing oligomers.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 23 条
[1]   APTAMERIC INHIBITION OF P210(BCR-ABL) TYROSINE KINASE AUTOPHOSPHORYLATION BY OLIGODEOXYNUCLEOTIDES OF DEFINED SEQUENCE AND BACKBONE STRUCTURE [J].
BERGAN, R ;
CONNELL, Y ;
FAHMY, B ;
KYLE, E ;
NECKERS, L .
NUCLEIC ACIDS RESEARCH, 1994, 22 (11) :2150-2154
[2]   TELOMERASES [J].
BLACKBURN, EH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :113-129
[3]   IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J].
BRANDA, RF ;
MOORE, AL ;
MATHEWS, L ;
MCCORMACK, JJ ;
ZON, G .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2037-2043
[4]  
BROWN DA, 1994, J BIOL CHEM, V269, P26801
[5]   THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM [J].
BURGESS, TL ;
FISHER, EF ;
ROSS, SL ;
BREADY, JV ;
QIAN, YX ;
BAYEWITCH, LA ;
COHEN, AM ;
HERRERA, CJ ;
HU, SSF ;
KRAMER, TB ;
LOTT, FD ;
MARTIN, FH ;
PIERCE, GF ;
SIMONET, L ;
FARRELL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4051-4055
[7]  
GAO WY, 1992, MOL PHARMACOL, V41, P223
[8]  
GILES RV, 1993, ANTI-CANCER DRUG DES, V8, P33
[9]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[10]   CPG MOTIFS IN BACTERIAL-DNA TRIGGER DIRECT B-CELL ACTIVATION [J].
KRIEG, AM ;
YI, AK ;
MATSON, S ;
WALDSCHMIDT, TJ ;
BISHOP, GA ;
TEASDALE, R ;
KORETZKY, GA ;
KLINMAN, DM .
NATURE, 1995, 374 (6522) :546-549